The Dr. Holhoș network has inaugurated the largest private ophthalmology hospital in Transylvania, following an investment of approximately €6 million.
Romanian patients wait, on average, 460 days to access innovative medicines, even after these therapies have been approved for reimbursement by the National Agency for Medicines and Medical Devices (ANMDM).
7X Partners, a private equity investment company, has acquired a 40% stake in Leventer Medical Group, a centre for dermato-oncology based in Bucharest.
The agreement signifies a joint commitment to enhance healthcare infrastructure in Romania.
ING Bank Romania has financed Medisprof Group, which owns the largest private oncology hospital in western Romania, to expand in the region of Moldova.
Banks in Central Eastern South-Eastern Europe report improving trends, with credit demand remaining robust, particularly from companies, while banks anticipate improvement in credit supply following a period of contraction.
Agroland Business System has completed the acquisition of Avirom, a Romanian company specialising in day-old chick and duckling production.
Romania's trade balance deficit (FOB/CIF) for January-November 2025 reached €29.77 billion, down €299.6 million (-1.0%) compared to the same period in 2024, according to data published by the National Institute of Statistics (INS).
The Romanian Chamber of Commerce and Industry (CCIR) has unanimously decided to support the free trade agreement between the EU and Mercosur, backing the decision made by the European Association of Chambers of Commerce (Eurochambres) at its November 2024 General Assembly.
Romania's Ministry of Finance has allocated over RON 3.8 billion (€760 million) to support public investments and clear arrears in key sectors including development, transport and agriculture.